News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Jonathan Strober, MD

Advertisement
Jonathan Strober, MD

Jonathan Strober, MD, Director of the Pediatric Neuromuscular Program and Professor of Pediatrics and Neurology at the University of California at San Francisco.

Articles by Jonathan Strober, MD

 Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

ByJoshua Fitch, Senior Editor ,Jonathan Strober, MD
November 26th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary Pediatrics

    1

    AAP publishes 2026 childhood and adolescent immunization schedule

    2

    AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy

    3

    FDA clears first at-home test to detect RSV, influenza, and COVID-19 in infants as young as 6 months

    4

    Genomic sequencing may transform newborn screening

    5

    Kathryn M. Stephenson, MD, MA, discusses GLP-1 RA decisions for pediatric obesity

    • About Us
    • Advertise
    • Contact Us
    • Editorial
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us